ERC-AG-LS4
ERC-AG-LS4
Programme: H2020
66 projects · €161,684,626 total EU contribution (project-level) · 53 participating organizations · 14 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€161,684,626
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (12)
- Germany (8)
- France (5)
- Italy (5)
- CH (4)
- Spain (4)
- SE (3)
- AT (2)
- FI (2)
- IL (2)
- Netherlands (2)
- DK (1)
- EL (1)
- LB (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI5 projects · SE
- EPFL4 projects · CH
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- ETH Zürich2 projects · CH
- IRB BARCELONA - CERCA2 projects · ES
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III2 projects · ES
- .2 projects · IT
- IMBA2 projects · AT
- ISTITUTO EUROPEO DI ONCOLOGIA SRL2 projects · IT
Projects
Page 4 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Genetics and epigenetics of Type 2 Diabetes physiology GEPIDIAB · 294785 | FP7 | €2,476,325 | €2,476,325 | Details |
Role of telomeres and stem cells in ageing ROOTS · 294740 | FP7 | €2,500,000 | €2,500,000 | Details |
Structure-Function Analysis of the Chemokine Interactome for Therapeutic Targeting and Imaging in Atherosclerosis ATHEROPROTECT · 249929 | FP7 | €2,500,000 | €2,500,000 | Details |
The lysine-specific demethylase1 (LSD1) in physiology and pathology LSD1 · 322844 | FP7 | €2,488,800 | €2,488,800 | Details |
Mechanisms of regulation of the blood-brain barrier; towards opening and closing the barrier on demand BBBARRIER · 294556 | FP7 | €2,499,427 | €2,499,427 | Details |
From flies to humans combining whole genome screens and tissue specific gene targeting to identify novel pathways involved in cancer and metastases COMBINE · 233407 | FP7 | €2,499,465 | €2,499,465 | Details |
Challenging the gaps in global cancer concepts by a real life tumor: human childhood neuroblastoma RealLifeCancer · 340735 | FP7 | €2,499,803 | €2,499,803 | Details |
HUMAN AND MOUSE MODELS OF RHINOVIRUS INDUCED ACUTE ASTHMA EXACERBATIONS MORIAE · 233015 | FP7 | €2,497,761 | €2,497,761 | Details |
Transcriptional regulation of endothelial blood brain barrier differentiation by Wnt signaling WNT FOR BRAIN · 268870 | FP7 | €2,390,200 | €2,390,200 | Details |
Identification of Novel Targeted Therapies for Renal Cancer ONCOTREAT · 323004 | FP7 | €2,247,890 | €2,247,890 | Details |